Cambridge Investment Research Advisors, Inc. Amgen Inc Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 108,825 shares of AMGN stock, worth $28.4 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

108,825

Previous 109,752 0.84%

Holding current value

$28.4 Million

Previous $34.3 Million 2.25%

% of portfolio

0.12%

Previous 0.13%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$309.38 - $337.38 $286,795 - $312,751	-927 Reduced 0.84%	108,825 $35.1 Million
Q2 2024 Jul 26, 2024	SELL	$262.75 - $319.31 $3 Million - $3.65 Million	-11,418 Reduced 9.42%	109,752 $34.3 Million
Q1 2024 Apr 24, 2024	BUY	$268.87 - $324.56 $46,514 - $56,148	173 Added 0.14%	121,170 $34.5 Million
Q4 2023 Feb 09, 2024	BUY	$255.7 - $288.46 $253,654 - $286,152	992 Added 0.83%	120,997 $34.9 Million
Q3 2023 Oct 24, 2023	BUY	$218.65 - $271.46 $1.99 Million - $2.47 Million	9,106 Added 8.21%	120,005 $32.3 Million
Q2 2023 Jul 13, 2023	BUY	$214.27 - $253.37 $205,913 - $243,488	961 Added 0.87%	110,899 $24.6 Million
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $3.6 Million - $4.39 Million	15,936 Added 16.95%	109,938 $26.6 Million
Q4 2022 Feb 08, 2023	BUY	$229.03 - $291.01 $127,569 - $162,092	557 Added 0.6%	94,002 $24.7 Million
Q3 2022 Oct 17, 2022	BUY	$224.46 - $253.15 $160,937 - $181,508	717 Added 0.77%	93,445 $21.1 Million
Q2 2022 Jul 13, 2022	BUY	$230.71 - $256.74 $223,327 - $248,524	968 Added 1.05%	92,728 $22.6 Million
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $365,742 - $404,606	1,668 Added 1.85%	91,760 $22.2 Million
Q4 2021 Feb 03, 2022	BUY	$198.88 - $227.6 $313,236 - $358,470	1,575 Added 1.78%	90,092 $20.3 Million
Q3 2021 Nov 02, 2021	BUY	$212.27 - $248.7 $1.03 Million - $1.2 Million	4,830 Added 5.77%	88,517 $18.8 Million
Q2 2021 Aug 10, 2021	BUY	$233.58 - $259.14 $919,838 - $1.02 Million	3,938 Added 4.94%	83,687 $20.4 Million
Q1 2021 May 07, 2021	BUY	$221.91 - $258.6 $104,297 - $121,542	470 Added 0.59%	79,749 $19.8 Million
Q4 2020 Feb 04, 2021	SELL	$216.38 - $257.67 $712,322 - $848,249	-3,292 Reduced 3.99%	79,279 $18.2 Million
Q3 2020 Oct 29, 2020	SELL	$234.65 - $260.95 $1.11 Million - $1.23 Million	-4,731 Reduced 5.42%	82,571 $21 Million
Q2 2020 Jul 27, 2020	BUY	$197.81 - $242.74 $358,431 - $439,844	1,812 Added 2.12%	87,302 $20.6 Million
Q1 2020 May 08, 2020	SELL	$182.24 - $241.7 $100,596 - $133,418	-552 Reduced 0.64%	85,490 $17.3 Million
Q4 2019 Feb 04, 2020	BUY	$189.21 - $243.2 $863,932 - $1.11 Million	4,566 Added 5.6%	86,042 $20.7 Million
Q3 2019 Nov 06, 2019	BUY	$174.11 - $208.62 $36,911 - $44,227	212 Added 0.26%	81,476 $15.8 Million
Q3 2019 Oct 28, 2019	SELL	$174.11 - $208.62 $82,876 - $99,303	-476 Reduced 0.58%	81,264 $15.7 Million
Q2 2019 Aug 15, 2019	BUY	$166.7 - $195.41 $802,660 - $940,899	4,815 Added 6.26%	81,740 $0
Q1 2019 May 08, 2019	SELL	$180.87 - $203.88 $1.14 Million - $1.29 Million	-6,307 Reduced 7.58%	76,925 $0
Q4 2018 Feb 05, 2019	BUY	$178.4 - $208.25 $141,471 - $165,142	793 Added 0.96%	83,232 $16.2 Million
Q3 2018 Nov 02, 2018	BUY	$185.29 - $208.89 $1 Million - $1.13 Million	5,403 Added 7.01%	82,439 $0
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $940,839 - $1.06 Million	-5,666 Reduced 6.85%	77,036 $0
Q1 2018 May 09, 2018	BUY	$169.43 - $198.0 $771,584 - $901,692	4,554 Added 5.83%	82,702 $0
Q4 2017 Feb 22, 2018	BUY	$168.79 - $188.59 $228,541 - $255,350	1,354 Added 1.76%	78,148 $0
Q3 2017 Nov 07, 2017	BUY	$167.29 - $191.0 $658,286 - $751,585	3,935 Added 5.4%	76,794 $14.3 Million
Q2 2017 Aug 08, 2017	BUY	N/A	72,859	72,859 $12.5 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account

Cambridge Investment Research Advisors, Inc. Amgen Inc Transaction History